Immunohistochemical myogenic markers such as SMA and desmin are important in differentiating LMSB from UPS, while focal malignant osteoid formation and negative myogenic markers help differentiate LMSB from fibroblastic osteosarcoma.[10]. This evidence concerns the gene DES and osteosarcoma.